Market Cap 513.30M
Revenue (ttm) 44.55M
Net Income (ttm) -83.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -188.06%
Debt to Equity Ratio -0.82
Volume 5,849,100
Avg Vol 1,617,750
Day's Range N/A - N/A
Shares Out 124.29M
Stochastic %K 68%
Beta 1.50
Analysts Strong Sell
Price Target $8.89

Company Profile

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 908 941 1900
Address:
30 Technology Drive, Warren, United States
UnderLion16
UnderLion16 May. 15 at 11:26 AM
$AQST https://www.linkedin.com/posts/cantor-is-proud-to-have-served-as-sole-placement-share-7460741831723474944-JPl7?utm_source=share&utm_medium=member_desktop&rcm=ACoAAEsd0XQB-kbKVWH1Winw4qDcCWoIeyftplo
0 · Reply
ae1213
ae1213 May. 15 at 10:49 AM
$AQST when tide goes out, market can see that $AQST swims naked. Gap will close and then some. I can see a 3 dollar land from my window!
1 · Reply
ae1213
ae1213 May. 15 at 10:46 AM
$SPRY $SPRY ohh silly sally, can’t sleep? Your post reeks of desperation. Here is the news for you - agreement with CVS Caremark before back to school is the final nail into $AQST coffin. As @dennisjackson used to say - you can stick a fork in it!
0 · Reply
RunnerSignals
RunnerSignals May. 15 at 7:39 AM
$AQST fda resubmission q3, $150M+ cash at launch. iq score 2.84 to 5.00, volume 4.8x
0 · Reply
HamBoneXoXo
HamBoneXoXo May. 14 at 11:32 PM
$AQST Today was like having chronic ED but suddenly getting hard presenting at a conference…
1 · Reply
JazzyJ03
JazzyJ03 May. 14 at 10:22 PM
$AQST nice volume today, wtg!
0 · Reply
Flipside69
Flipside69 May. 14 at 8:03 PM
$AQST A very nice day!
1 · Reply
Ilygod
Ilygod May. 14 at 7:38 PM
$AQST Shorts are going to feel the squeeze all the way to $20 when FDA approves the life saving and life changing treatment for severe allergy. To force people to jab a needle into them when they can't breath is inhumane. A sublingual or buccal treatment...irrefutable. BO
2 · Reply
ITrustno1
ITrustno1 May. 14 at 6:22 PM
$AQST safest Long investment in BIO today IMO. 100% return min over 1yr. With 1000% return over 5yrs. $5B MC is possible when this is the SOC in the 2030’s Incredible to be in early Happy to be alive …short term swings expected and to be used to maximize total share count, or just ignored and let the stew cook.🧑‍🍳
0 · Reply
ae1213
ae1213 May. 14 at 5:22 PM
$AQST let’s close that gap, kids! I need to cover.
0 · Reply
Latest News on AQST
Aquestive Therapeutics Earnings Call Transcript: Q1 2026

May 14, 2026, 8:00 AM EDT - 23 hours ago

Aquestive Therapeutics Earnings Call Transcript: Q1 2026


Aquestive Therapeutics Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:00 AM EST - 2 months ago

Aquestive Therapeutics Earnings Call Transcript: Q4 2025


Aquestive CRL from FDA ‘clearing event,’ says Oppenheimer

2026-02-02T15:40:09.000Z - 3 months ago

Aquestive CRL from FDA ‘clearing event,’ says Oppenheimer


Aquestive Therapeutics Transcript: Status update

Feb 2, 2026, 8:00 AM EST - 3 months ago

Aquestive Therapeutics Transcript: Status update


Aquestive Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 6 months ago

Aquestive Therapeutics Earnings Call Transcript: Q3 2025


Aquestive Therapeutics Broadens Patent Estate for Anaphylm™

Oct 8, 2025, 7:00 AM EDT - 7 months ago

Aquestive Therapeutics Broadens Patent Estate for Anaphylm™


Aquestive Therapeutics Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:00 AM EDT - 9 months ago

Aquestive Therapeutics Earnings Call Transcript: Q2 2025


UnderLion16
UnderLion16 May. 15 at 11:26 AM
$AQST https://www.linkedin.com/posts/cantor-is-proud-to-have-served-as-sole-placement-share-7460741831723474944-JPl7?utm_source=share&utm_medium=member_desktop&rcm=ACoAAEsd0XQB-kbKVWH1Winw4qDcCWoIeyftplo
0 · Reply
ae1213
ae1213 May. 15 at 10:49 AM
$AQST when tide goes out, market can see that $AQST swims naked. Gap will close and then some. I can see a 3 dollar land from my window!
1 · Reply
ae1213
ae1213 May. 15 at 10:46 AM
$SPRY $SPRY ohh silly sally, can’t sleep? Your post reeks of desperation. Here is the news for you - agreement with CVS Caremark before back to school is the final nail into $AQST coffin. As @dennisjackson used to say - you can stick a fork in it!
0 · Reply
RunnerSignals
RunnerSignals May. 15 at 7:39 AM
$AQST fda resubmission q3, $150M+ cash at launch. iq score 2.84 to 5.00, volume 4.8x
0 · Reply
HamBoneXoXo
HamBoneXoXo May. 14 at 11:32 PM
$AQST Today was like having chronic ED but suddenly getting hard presenting at a conference…
1 · Reply
JazzyJ03
JazzyJ03 May. 14 at 10:22 PM
$AQST nice volume today, wtg!
0 · Reply
Flipside69
Flipside69 May. 14 at 8:03 PM
$AQST A very nice day!
1 · Reply
Ilygod
Ilygod May. 14 at 7:38 PM
$AQST Shorts are going to feel the squeeze all the way to $20 when FDA approves the life saving and life changing treatment for severe allergy. To force people to jab a needle into them when they can't breath is inhumane. A sublingual or buccal treatment...irrefutable. BO
2 · Reply
ITrustno1
ITrustno1 May. 14 at 6:22 PM
$AQST safest Long investment in BIO today IMO. 100% return min over 1yr. With 1000% return over 5yrs. $5B MC is possible when this is the SOC in the 2030’s Incredible to be in early Happy to be alive …short term swings expected and to be used to maximize total share count, or just ignored and let the stew cook.🧑‍🍳
0 · Reply
ae1213
ae1213 May. 14 at 5:22 PM
$AQST let’s close that gap, kids! I need to cover.
0 · Reply
h8ster
h8ster May. 14 at 4:46 PM
$AQST Ignore the volatility of the price action today. Up down, up down, up down, who cares. The stock just has to cycle through the earnings swing traders over the next couple of days. Let them run around like chickens with their heads cut off trying to time a nickel and dime. Let that be their ignorant stress, not yours. We also might see some resistance from option underwriters who aren't holding inventory for the May 15 calls. PPs can go either way by eod tomorrow. Be happy for whats coming in the coming days and weeks. Watch for positive analyst adjustments, with the majority of what used to be risk, now taken off the boards. The near term is irrelevant with the crazy market environment we are in and at least here, we know we will be up far more by the end of the year. I will be back to buying small blocks on any pullbacks and dips up to FDA approval. Let the foolish fret and complain and die a slow financial death. They are just noise. Tune them out.
5 · Reply
drew64
drew64 May. 14 at 4:31 PM
$AQST Looks like $5.50 all day to me. Low volume days the last 2 months, almost break outish, atleast from the range. Up is up🤙🏼🍻😎
0 · Reply
UnderLion16
UnderLion16 May. 14 at 4:20 PM
$AQST 🥰 https://www.youtube.com/watch?v=wC_kCnm3GYQ
0 · Reply
BigGainTom
BigGainTom May. 14 at 4:19 PM
$AQST $5 at close today or nahh?
2 · Reply
Rock6Times
Rock6Times May. 14 at 3:57 PM
$AQST With the expanding pipeline - is worth way more than $600M
0 · Reply
AnalyticalDog
AnalyticalDog May. 14 at 3:25 PM
$AQST came back to see how things are going and wow. The permabears always have something to bitch about. Why in the hell would you still be commenting for a full year after you decided the company was going nowhere. Get a fucking life.
1 · Reply
faz999
faz999 May. 14 at 3:16 PM
$AQST upgrades coming tomorrow Anaylyst finishing up the report. Will post should take us over $5 tomorrow
0 · Reply
Stone52
Stone52 May. 14 at 3:04 PM
0 · Reply
BDE_Worldwide
BDE_Worldwide May. 14 at 2:51 PM
0 · Reply
Bwanie
Bwanie May. 14 at 2:27 PM
$AQST almost out of the red, been a long road!
2 · Reply
ae1213
ae1213 May. 14 at 2:25 PM
$AQST it increasingly looks like they will be lucky to get a go ahead from the FDA at the end of q2. This means that the approval/CRL will come in q2-3 of 2027! Libervant, anyone?
1 · Reply
Stone52
Stone52 May. 14 at 2:16 PM
$AQST they basically said they are being held up by the FDA’s responses before even starting a HF or PL trial. So, no trials that address the CRL have even started.
2 · Reply